Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 6:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2329–2352 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Heart Diseases, Diabetes Mellitus, Type 2, Pre-diabetes, Hypertension, Hyperlipidemias
Interventions: Cardiovascular Risk Homeless Support; Behavioral
Lead sponsor: Katherine Vickery; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Metabolic Syndrome X, Overweight, Hypertension, Dyslipidemias, Prediabetic State
Interventions: Chloroquine, Placebo Comparator; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 357 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hypertension
Interventions: Artificial Intelligence (AI) Activity, 10,000 steps; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hypertension, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: lisinopril, losartan potassium, laboratory biomarker analysis, benazepril hydrochloride, ramipril; Drug · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Diabetes Mellitus ( Type 1 and Type 2), Hypertension
Interventions: Guide My Care Tool; Other
Lead sponsor: Fitbit LLC; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Hypertension, Diabetes Mellitus, Hyperlipidemia
Interventions: telemedicine; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 22 Years to 85 Years
Enrollment: 465 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 3
States / cities: Danville, Pennsylvania • Philadelphia, Pennsylvania

Conditions: Hypertension, Undiagnosed Diseases
Interventions: PAL2; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 95 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases, Cardiovascular Diseases, Fibrosis
Interventions: Mosliciguat, Placebo, Dry Powder Inhaler; Drug · Device
Lead sponsor: Pulmovant, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: Kissimmee, Florida • Louisville, Kentucky • Bend, Oregon

Conditions: Pulmonary Hypertension, Insomnia, Fatigue
Interventions: CBT-I, Bright Light Therapy; Behavioral · Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Glaucoma
Interventions: Ologen; Procedure
Lead sponsor: The New York Eye & Ear Infirmary; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Open Angle Glaucoma, Ocular Hypertension, Pseudoexfoliation Syndrome
Interventions: Travatan, Azopt, Alphagan P; Drug
Lead sponsor: Hermann Eye Center; Other
Eligibility: 35 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2005
U.S. locations: 21
States / cities: Los Angeles, California • Hamden, Connecticut • Gainesville, Florida + 14 more

Conditions: Hypertension
Interventions: Renal Denervation; Device
Lead sponsor: Medtronic Vascular; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 3
States / cities: Springfield, Illinois • Minneapolis, Minnesota • Cleveland, Ohio

Conditions: Preeclampsia
Interventions: Recombinant human antithrombin (ATryn), Normal Saline 0.9%; Biological · Other
Lead sponsor: rEVO Biologics; Industry
Eligibility: 16 Years and older · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 23
States / cities: Birmingham, Alabama • Mobile, Alabama • Little Rock, Arkansas + 19 more

Conditions: Idiopathic Intracranial Hypertension
Interventions: MR elastography, MRI structural brain imaging, Lumbar puncture, Optical Coherence Tomography (OCT) imaging, Optic nerve B-scan ultrasound; Diagnostic Test · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2031
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hypertension
Interventions: Ecological Nurse Case Management; Behavioral
Lead sponsor: Bev Zabler; Other
Eligibility: 30 Years to 65 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Cardiometabolic Conditions, Hypertension (HTN), Dyslipidemia, Pre-diabetes, Type 2 Diabetes Mellitus (T2DM), Overweight (BMI > 25), Weight Loss Trial
Interventions: PILI (Partnership for Improving Lifestyle Intervention) Pasifika Program; Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Fayetteville, Arkansas • Honolulu, Hawaii

Conditions: Open-Angle Glaucoma, Ocular Hypertension
Interventions: IOP Lowering Medications; Drug
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2004
U.S. locations: 3
States / cities: Los Angeles, California • San Francisco, California • Honolulu, Hawaii

Conditions: Heart Failure, Hypertension, Diabetes Mellitus, Stroke, BPH, Hyperlipidemia
Interventions: Virtual Visit; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: Yoga session; Behavioral
Lead sponsor: Texas State University; Other
Eligibility: 20 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Marcos, Texas

Conditions: Glaucoma
Interventions: XyCAM with oxygen; Device
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 88 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chronic Kidney Diseases, Hypertension
Interventions: Computerized CKD Education, Usual Hospital Care; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes
Interventions: Intensive diabetes self-management education, Enhanced standard diabetes education; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Kidney Injury, Cirrhosis, Portal Hypertension, Hepatorenal Syndrome, Acute Tubule Necrosis, Prerenal Failure
Interventions: MAP-Target Algorithm; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Diabetes Mellitus, Metabolic Syndrome, Hypertension, Chronic Disease
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 28,813 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 6
States / cities: Chinle, Arizona • Fort Defiance, Arizona • Kayenta, Arizona + 3 more

Search by objective public record fields.

Behavior Change Intervention for Cardiovascular Risk Reduction Among People Experiencing Homelessness

Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)

AI Activity Study in Patients With Elevated Blood Pressure

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

Care COMPASS Study

Preventing Heart Disease in Underserved Patients

Project 1: ACHIEVE- HTN

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

Cognitive Behavioral Therapy and Light Therapy

The Effectiveness of Ologen® Collagen Matrix in Preventing Intraocular Pressure (IOP) Spikes After Ahmed Glaucoma Valve Surgery (AGV-FP7)

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

Renal Denervation in Patients With Refractory Hypertension

Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia

Evaluating Raised Intracranial Pressure Using MR Elastography

Promoting Self-Management in Low Income African Americans Living With Hypertension

To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years

Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98

Virtual Visits at Brigham and Women's Hospital

Acute Effects of Vinyasa Yoga on Vascular Function

Ocular Blood Flow Imaging for Glaucoma Assessment

Interactive Computer-adaptive Chronic Kidney Disease Education Program

Self-Management in African Americans With Diabetes and Hypertension

NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients

Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program